Acute inflammation promotes a hypercoagulable state that may increase the risk of deep vein thrombosis (DVT) and pulmonary embolism.
1 In chronic inflammatory disease such as rheumatoid arthritis (RA), procoagulatory factors are up-regulated.
2,3 Few studies have assessed how this theoretical inflammation-induced risk of venous thromboembolism (VTE) translates into risk for clinical events in patients with RA.
4-9